The Cannabis Pharmaceuticals Market is Projected to Reach $85.68 Billion by 2030 Driven by Robust Industry Expansion

Cannabis Pharmaceuticals Market

The Business Research Company's Cannabis Pharmaceuticals Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, November 10, 2026 /EINPresswire.com/ -- "The cannabis pharmaceuticals sector has been witnessing remarkable growth, reflecting a broader acceptance and integration of cannabinoid-based treatments within the medical field. As therapeutic uses of cannabis continue to expand, the market is set for considerable advancements in the coming years. Below is an overview of the market’s size, key drivers, regional leadership, and emerging trends shaping this fast-evolving industry.

Cannabis Pharmaceuticals Market Size and Growth Outlook
The cannabis pharmaceuticals market has experienced rapid expansion in recent years. The market value is projected to increase from $9.43 billion in 2025 to $14.74 billion in 2026, marking an impressive compound annual growth rate (CAGR) of 56.3%. This surge during the historical period has been driven by growing acknowledgment of the therapeutic potential of cannabinoids, the rise in medical cannabis prescriptions, the availability of early cannabis-derived drugs, as well as the expansion of hospital-based pain management programs and regulatory approvals for specific cannabis medications.

Download a free sample of the cannabis pharmaceuticals market report:
https://thebusinessresearchcompany.com/sample_request?id=45060954&type=smp&name=Cannabis%20Pharmaceuticals%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

Looking further ahead, the market is expected to continue its exponential climb, reaching $85.68 billion by 2030 with a steady CAGR of 55.3%. Growth in this forecast period is propelled by greater investment in cannabis drug clinical trials, rising demand for standardized cannabinoid products, increasing applications in neurological and oncology treatments, wider adoption of cannabis pharmaceuticals in hospital settings, and more harmonized regulations across various markets. Among the dominant trends anticipated are the development of prescription-grade cannabis medicines, enhanced focus on clinical validation and trials, expanded use in neurological and pain-related disorders, growth of regulated pharmaceutical pipelines, and improved precision in dosing.

Understanding Cannabis Pharmaceuticals and Their Applications
Cannabis pharmaceuticals refer to prescription medications formulated from cannabis-derived compounds and manufactured according to rigorous clinical and regulatory standards. These drugs leverage cannabinoids like tetrahydrocannabinol (THC) and cannabidiol (CBD) to treat specific medical conditions such as chronic pain, epilepsy, and multiple sclerosis. By offering targeted therapeutic benefits, these medications provide patients with alternatives to traditional treatments, often delivering improved outcomes for complex health issues.

View the full cannabis pharmaceuticals market report:
https://thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR

What Is Driving Cannabis Pharmaceuticals Market Expansion?
One of the primary factors fueling market growth is the rising prevalence of epilepsy, a neurological disorder characterized by recurring, unprovoked seizures caused by abnormal brain electrical activity. The increase in epilepsy cases is linked to improved diagnosis, greater public awareness, more comprehensive reporting, and potential environmental, genetic, and lifestyle contributors. Cannabis-derived pharmaceuticals have demonstrated effectiveness in managing epilepsy, particularly through the use of CBD, which can reduce the frequency and severity of seizures among patients resistant to conventional anti-epileptic medications. For example, a report from the World Health Organization in February 2024 highlighted that approximately 50 million individuals worldwide are living with epilepsy, underscoring the significant market opportunity presented by this condition.

Regional Leadership and Growth Trends in the Cannabis Pharmaceuticals Market
In 2025, North America held the largest share of the global cannabis pharmaceuticals market, reflecting its early adoption and favorable regulatory environment. Meanwhile, the Asia-Pacific region is projected to be the fastest-growing market throughout the forecast period. The comprehensive market analysis covers several regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on market dynamics and opportunities.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X